Patent · US Active

Compositions and methods for treating joints

US8398611B2 · kind B2 · utility

15Cited by
71References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 28, 2010
Grant dateMar 19, 2013
Priority date
Expiry dateDec 28, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods are provided for treating joint conditions, such as osteoarthritis and/or the pain associated therewith. The compositions and methods utilize a first component, namely hyaluraonic acid (“HA”), in combination with a lyophilized second component that is effective to at least temporarily reduce the viscosity of the HA. In an exemplary embodiment, the second component is one or more glycosaminoglycans (“GAG”), such as chondroitin sulfate (“CS”), including CS4 and/or CS6, dermatan sulfate, heparin, heparan sulfate, and keratan sulfate. The composition can optionally include other joint supplements, such as glucosamine (“GlcN”).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.